Today in our #NYC newsletter: $HCM and Innovent Jointly Announce NMPA Conditional Approval for ELUNATE in Combination with TYVYT for the Treatment of Advanced Endometrial Cancer; $MNMD Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy

For more updates in #lifescience and #biotech, subscribe to our daily newsletter:
#NYC #HCM #MNMD